2019 - 2022 Elucidation of the molecular mechanism of CYP3A4 induction in the human intestine and its differences from the liver
2021 - 上皮間葉転換に注目した肝がんの進行を抑制する医薬品のスクリーニングと治療効果の検証
2019 - 2021 Identification of the molecular mechanism of nuclear receptor CAR-mediated liver carcinogenesis and its species differences.
2017 - 2020 Nuclear receptor PXR-mediated hepatocyte proliferation: understanding of its mechanism and human relevance
2017 - 2020 Development of evaluation methods for drug-induced liver injury based on both chemical structure/biological reactivity of drugs and individual factors
2020 - 核内受容体 CAR のヒト型変異導入マウスを用いた肝発がんプロモーションの機序解析
2017 - 2019 Establishment of in vitro evaluation system for the activation of nuclear receptor CAR and PXR
Show all
Papers (43):
Takumi Sato, Ryota Shizu, Ryonosuke Baba, Akira Ooka, Takuomi Hosaka, Yuichiro Kanno, Kouichi Yoshinari. Pregnane X receptor inhibits the transdifferentiation of hepatic stellate cells by downregulating periostin expression. Biochemical journal. 2024
Shunnosuke Kaito, Jun-ichi Takeshita, Misaki Iwata, Takamitsu Sasaki, Takuomi Hosaka, Ryota Shizu, Kouichi Yoshinari. Utility of human cytochrome P450 inhibition data in the assessment of drug-induced liver injury. Xenobiotica. 2024
Ryota Shizu, Natsuki Makida, Keiichiro Sobe, Mai Ishimura, Aki Takeshita, Takuomi Hosaka, Yuichiro Kanno, Takamitsu Sasaki, Kouichi Yoshinari. Interaction with YAP underlies the species differences between humans and rodents in CAR-dependent hepatocyte proliferation. Toxicological sciences : an official journal of the Society of Toxicology. 2023
佐藤拓海, 志津怜太, 保坂卓臣, 佐々木崇光, 菅野裕一朗, 吉成浩一. Mechanism of the nuclear receptor PXR-mediated suppression of transdifferentiation of hepatic stellate cells. 日本薬学会年会要旨集(Web). 2023. 143rd
志津怜太, 佐藤拓海, 三浦佳恵, 保坂卓臣, 菅野裕一朗, 佐々木崇光, 吉成浩一. Screening of nuclear receptor CAR and PPARα activation potential of chemicals which cause liver cancer in rat carcinogenicity test. 衛生薬学・環境トキシコロジー講演要旨集. 2022. 2022
佐藤拓海, 志津怜太, 志津怜太, 馬場遼之介, 石村麻衣, 保坂卓臣, 保坂卓臣, 佐々木崇光, 菅野裕一朗, 菅野裕一朗, et al. Mechanism of the nuclear receptor PXR-mediated suppression of epithelial-mesenchymal transition of liver cancer cells. 日本薬学会年会要旨集(Web). 2022. 142nd
馬場遼之介, 志津怜太, 佐藤拓海, 保坂卓臣, 菅野裕一朗, 吉成浩一. Evaluation of the influence of PXR activation on epithelial-mesenchymal transition of liver cancer cells using reporter assay with the VIMENTIN promoter. 衛生薬学・環境トキシコロジー講演要旨集. 2022. 2022
佐藤拓海, 志津怜太, 志津怜太, 馬場遼之介, 石村麻衣, 保坂卓臣, 保坂卓臣, 佐々木崇光, 菅野裕一朗, 菅野裕一朗, et al. A mechanism for the nuclear receptor PXR-mediated suppression of liver cancer progression. Journal of Toxicological Sciences. 2022. 47. Supplement (CD-ROM)
2023/07 - 現在 University of Shizuoka School of Pharmaceutical Sciences
2017/04 - 2023/06 University of Shizuoka School of Pharmaceutical Sciences
2016/03 - 2017/03 日本学術振興会 海外特別研究員(NIH)
2014/04 - 2017/03 NIEHS/NIH 博士研究員
Committee career (2):
2024 - 現在 日本毒性学会 評議員
2023/09 - 日本薬物動態学会第38回年会第23回シトクロムP450国際合同大会 実行委員長
Awards (11):
2023/09 - 日本薬学会環境・衛生部会 部会賞・金原賞
2022/12 - 静岡県立大学 学長表彰
2022/07 - 日本薬学会東海支部 学術奨励賞
2022/07 - 日本毒性学会 田邊賞
2022/07 - 日本毒性学会 奨励賞
2021/10 - The 80th Annual Meeting of the Japanese Cancer Association Poster award PXR activation might attenuate the liver cancer development by preventing EMT of liver cancer cells
2019/07 - 12th International ISSX Meeting Postdoctoral Poster award 3rd Place
2019/06 - 日本毒性学会 田邊賞
2019/01 - 日本毒性学会第1回医薬品毒性機序研究会 優秀発表賞
2016/10 - The 21st International Symposium on Microsomes and Drug Oxidations Best poster award
2015/07 - Gordon Research Conference (Drug Metabolism) Travel grant
Show all
Association Membership(s) (6):
THE JAPANESE CANCER ASSOCIATION
, THE JAPANESE SOCIETY FOR THE STUDY OF XENOBIOTICS
, THE JAPANESE SOCIETY OF TOXICOLOGY
, THE PHARMACEUTICAL SOCIETY OF JAPAN
, 日本生化学会
, ISSX